Arterial  ||| S:0 E:9 ||| FW
remodeling  ||| S:9 E:20 ||| FW
in  ||| S:20 E:23 ||| FW
middle  ||| S:23 E:30 ||| FW
cerebral  ||| S:30 E:39 ||| FW
artery  ||| S:39 E:46 ||| FW
atherosclerotic  ||| S:46 E:62 ||| FW
stenosis ||| S:62 E:70 ||| FW
: ||| S:70 E:71 ||| :
a  ||| S:71 E:73 ||| DT
high-resolution  ||| S:73 E:89 ||| JJ
MRI  ||| S:89 E:93 ||| NNP
study  ||| S:93 E:99 ||| NN
To  ||| S:99 E:102 ||| TO
investigate  ||| S:102 E:114 ||| VB
remodeling  ||| S:114 E:125 ||| VBG
mode  ||| S:125 E:130 ||| NN
of  ||| S:130 E:133 ||| IN
moderate  ||| S:133 E:142 ||| JJ
or  ||| S:142 E:145 ||| CC
severe  ||| S:145 E:152 ||| JJ
atherosclerotic  ||| S:152 E:168 ||| JJ
stenosis  ||| S:168 E:177 ||| NN
of  ||| S:177 E:180 ||| IN
the  ||| S:180 E:184 ||| DT
middle  ||| S:184 E:191 ||| JJ
cerebral  ||| S:191 E:200 ||| JJ
artery  ||| S:200 E:207 ||| NN
( ||| S:207 E:208 ||| -LRB-
MCA ||| S:208 E:211 ||| NNP
)  ||| S:211 E:213 ||| -RRB-
using  ||| S:213 E:219 ||| VBG
high  ||| S:219 E:224 ||| JJ
resolution  ||| S:224 E:235 ||| NN
MRI ||| S:235 E:238 ||| NNP
.  ||| S:238 E:240 ||| .
Thirty-seven  ||| S:240 E:253 ||| JJ
consecutive  ||| S:253 E:265 ||| JJ
symptomatic  ||| S:265 E:277 ||| JJ
patients  ||| S:277 E:286 ||| NNS
with  ||| S:286 E:291 ||| IN
atherosclerotic  ||| S:291 E:307 ||| JJ
MCA  ||| S:307 E:311 ||| NNP
stenosis  ||| S:311 E:320 ||| NN
were  ||| S:320 E:325 ||| VBD
imaged  ||| S:325 E:332 ||| VBN
with  ||| S:332 E:337 ||| IN
a  ||| S:337 E:339 ||| DT
3.0-T  ||| S:339 E:345 ||| JJ
magnetic  ||| S:345 E:354 ||| JJ
resonance  ||| S:354 E:364 ||| NN
scanner ||| S:364 E:371 ||| NN
.  ||| S:371 E:373 ||| .
The  ||| S:373 E:377 ||| DT
HR-MRI  ||| S:377 E:384 ||| JJ
protocol  ||| S:384 E:393 ||| NN
included  ||| S:393 E:402 ||| VBD
four  ||| S:402 E:407 ||| CD
different  ||| S:407 E:417 ||| JJ
scans ||| S:417 E:422 ||| NNS
:  ||| S:422 E:424 ||| :
T1-weighted  ||| S:424 E:436 ||| CD
black  ||| S:436 E:442 ||| JJ
blood  ||| S:442 E:448 ||| NN
imaging ||| S:448 E:455 ||| NN
,  ||| S:455 E:457 ||| ,
T2-weighted  ||| S:457 E:469 ||| NNP
MR ||| S:469 E:471 ||| NNP
,  ||| S:471 E:473 ||| ,
proton  ||| S:473 E:480 ||| FW
density  ||| S:480 E:488 ||| FW
( ||| S:488 E:489 ||| -LRB-
PD ||| S:489 E:491 ||| NNP
) ||| S:491 E:492 ||| -RRB-
-weighted  ||| S:492 E:502 ||| NNP
MR ||| S:502 E:504 ||| NNP
,  ||| S:504 E:506 ||| ,
and  ||| S:506 E:510 ||| CC
3D-SPACE ||| S:510 E:518 ||| NNP
.  ||| S:518 E:520 ||| .
The  ||| S:520 E:524 ||| DT
wall  ||| S:524 E:529 ||| NN
area  ||| S:529 E:534 ||| NN
( ||| S:534 E:535 ||| -LRB-
VA ||| S:535 E:537 ||| NNP
) ||| S:537 E:538 ||| -RRB-
,  ||| S:538 E:540 ||| ,
lumen  ||| S:540 E:546 ||| JJ
area  ||| S:546 E:551 ||| NN
( ||| S:551 E:552 ||| -LRB-
LA ||| S:552 E:554 ||| NNP
)  ||| S:554 E:556 ||| -RRB-
and  ||| S:556 E:560 ||| CC
plaque  ||| S:560 E:567 ||| JJ
area  ||| S:567 E:572 ||| NN
( ||| S:572 E:573 ||| -LRB-
PA ||| S:573 E:575 ||| NNP
)  ||| S:575 E:577 ||| -RRB-
were  ||| S:577 E:582 ||| VBD
calculated ||| S:582 E:592 ||| VBN
.  ||| S:592 E:594 ||| .
The  ||| S:594 E:598 ||| DT
characterization  ||| S:598 E:615 ||| NN
of  ||| S:615 E:618 ||| IN
the  ||| S:618 E:622 ||| DT
plaque  ||| S:622 E:629 ||| NN
on  ||| S:629 E:632 ||| IN
HR-MRI  ||| S:632 E:639 ||| NNP
was  ||| S:639 E:643 ||| VBD
analysed ||| S:643 E:651 ||| VBN
.  ||| S:651 E:653 ||| .
And  ||| S:653 E:657 ||| CC
the  ||| S:657 E:661 ||| DT
difference  ||| S:661 E:672 ||| NN
between  ||| S:672 E:680 ||| IN
positive  ||| S:680 E:689 ||| JJ
remodeling  ||| S:689 E:700 ||| NN
( ||| S:700 E:701 ||| -LRB-
PR ||| S:701 E:703 ||| NNP
)  ||| S:703 E:705 ||| -RRB-
and  ||| S:705 E:709 ||| CC
non-postive  ||| S:709 E:721 ||| JJ
remodeling  ||| S:721 E:732 ||| NN
( ||| S:732 E:733 ||| -LRB-
non-PR ||| S:733 E:739 ||| NNP
)  ||| S:739 E:741 ||| -RRB-
was  ||| S:741 E:745 ||| VBD
explored ||| S:745 E:753 ||| VBN
.  ||| S:753 E:755 ||| .
Thirty-four  ||| S:755 E:767 ||| CD
patients  ||| S:767 E:776 ||| NNS
imaging  ||| S:776 E:784 ||| NN
was  ||| S:784 E:788 ||| VBD
appropriate  ||| S:788 E:800 ||| JJ
for  ||| S:800 E:804 ||| IN
analyse ||| S:804 E:811 ||| NN
.  ||| S:811 E:813 ||| .
Positive  ||| S:813 E:822 ||| JJ
remodeling  ||| S:822 E:833 ||| NN
was  ||| S:833 E:837 ||| VBD
found  ||| S:837 E:843 ||| VBN
in  ||| S:843 E:846 ||| IN
19  ||| S:846 E:849 ||| CD
lesions ||| S:849 E:856 ||| NNS
.  ||| S:856 E:858 ||| .
Compared  ||| S:858 E:867 ||| VBN
with  ||| S:867 E:872 ||| IN
the  ||| S:872 E:876 ||| DT
non-PR  ||| S:876 E:883 ||| JJ
group ||| S:883 E:888 ||| NN
,  ||| S:888 E:890 ||| ,
the  ||| S:890 E:894 ||| DT
PR  ||| S:894 E:897 ||| NNP
group  ||| S:897 E:903 ||| NN
had  ||| S:903 E:907 ||| VBD
greater  ||| S:907 E:915 ||| JJR
WA  ||| S:915 E:918 ||| NNP
[ ||| S:918 E:919 ||| -LRB-
( ||| S:919 E:920 ||| -LRB-
10.9  ||| S:920 E:925 ||| CD
±  ||| S:925 E:927 ||| CD
2.5 ||| S:927 E:930 ||| CD
)  ||| S:930 E:932 ||| -RRB-
mm²  ||| S:932 E:936 ||| NNP
and  ||| S:936 E:940 ||| CC
( ||| S:940 E:941 ||| -LRB-
9.2  ||| S:941 E:945 ||| CD
±  ||| S:945 E:947 ||| CD
1.9 ||| S:947 E:950 ||| CD
)  ||| S:950 E:952 ||| -RRB-
mm² ||| S:952 E:955 ||| NNP
,  ||| S:955 E:957 ||| ,
P  ||| S:957 E:959 ||| NN
=  ||| S:959 E:961 ||| SYM
0.039 ||| S:961 E:966 ||| CD
) ||| S:966 E:967 ||| -RRB-
]  ||| S:967 E:969 ||| -RRB-
and  ||| S:969 E:973 ||| CC
greater  ||| S:973 E:981 ||| JJR
PA  ||| S:981 E:984 ||| NNP
[ ||| S:984 E:985 ||| -LRB-
( ||| S:985 E:986 ||| -LRB-
6.4  ||| S:986 E:990 ||| CD
±  ||| S:990 E:992 ||| CD
1.9 ||| S:992 E:995 ||| CD
)  ||| S:995 E:997 ||| -RRB-
mm²  ||| S:997 E:1001 ||| NNP
and  ||| S:1001 E:1005 ||| CC
( ||| S:1005 E:1006 ||| -LRB-
3.9  ||| S:1006 E:1010 ||| CD
±  ||| S:1010 E:1012 ||| CD
1.1 ||| S:1012 E:1015 ||| CD
)  ||| S:1015 E:1017 ||| -RRB-
mm² ||| S:1017 E:1020 ||| NNP
,  ||| S:1020 E:1022 ||| ,
P  ||| S:1022 E:1024 ||| NN
=  ||| S:1024 E:1026 ||| SYM
0 ||| S:1026 E:1027 ||| CD
] ||| S:1027 E:1028 ||| -RRB-
.  ||| S:1028 E:1030 ||| .
High  ||| S:1030 E:1035 ||| JJ
intensity  ||| S:1035 E:1045 ||| NN
on  ||| S:1045 E:1048 ||| IN
DWI  ||| S:1048 E:1052 ||| NNP
and  ||| S:1052 E:1056 ||| CC
irregularity  ||| S:1056 E:1069 ||| NN
of  ||| S:1069 E:1072 ||| IN
plaque  ||| S:1072 E:1079 ||| JJ
surface  ||| S:1079 E:1087 ||| NN
were  ||| S:1087 E:1092 ||| VBD
more  ||| S:1092 E:1097 ||| RBR
frequently  ||| S:1097 E:1108 ||| RB
observed  ||| S:1108 E:1117 ||| VBN
in  ||| S:1117 E:1120 ||| IN
PR  ||| S:1120 E:1123 ||| NNP
than  ||| S:1123 E:1128 ||| IN
non-PR ||| S:1128 E:1134 ||| JJ
.  ||| S:1134 E:1136 ||| .
In  ||| S:1136 E:1139 ||| IN
patients  ||| S:1139 E:1148 ||| NNS
with  ||| S:1148 E:1153 ||| IN
MCA  ||| S:1153 E:1157 ||| NNP
atherosclerosis ||| S:1157 E:1172 ||| NN
,  ||| S:1172 E:1174 ||| ,
PR  ||| S:1174 E:1177 ||| NNP
lesions  ||| S:1177 E:1185 ||| NNS
contain  ||| S:1185 E:1193 ||| VBP
larger  ||| S:1193 E:1200 ||| JJR
plaques  ||| S:1200 E:1208 ||| NN
than  ||| S:1208 E:1213 ||| IN
non-PR  ||| S:1213 E:1220 ||| JJ
lesions  ||| S:1220 E:1228 ||| NNS
and  ||| S:1228 E:1232 ||| CC
are  ||| S:1232 E:1236 ||| VBP
probably  ||| S:1236 E:1245 ||| RB
with  ||| S:1245 E:1250 ||| IN
high  ||| S:1250 E:1255 ||| JJ
risk  ||| S:1255 E:1260 ||| NN
for  ||| S:1260 E:1264 ||| IN
plaque  ||| S:1264 E:1271 ||| JJ
rupture  ||| S:1271 E:1279 ||| NN
and  ||| S:1279 E:1283 ||| CC
subsequent  ||| S:1283 E:1294 ||| JJ
stroke ||| S:1294 E:1300 ||| NN
.  ||| S:1300 E:1302 ||| .
